Serono Rebif 25% Market Share Expected By 2006; Monthly Price Is $1,156

Serono hopes Rebif will capture a quarter of the multiple sclerosis market by 2006, CEO Ernesto Bertarelli told securities analysts during a March 11 conference call

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet